Table 1 (abstract P043). Relative change in variables from index to 6 month follow up visit stratified by disease activity state at index visit. Minimal clinical important difference for each variable were determined to be: pain interference improvement -3 and worsening +3, mobility and global health improvement +3 and worsening -3
From: Proceedings of the 28th European Paediatric Rheumatology Congress (PReS 2022)
| Â | Change from index to 6 month visit | cJADAS ID | cJADAS LDA | ACRCID | Wallace | Not cJADAS ID | Not cJADAS LDA | Not ACRCID | Not Wallace |
|---|---|---|---|---|---|---|---|---|---|
Pain inter-ference | improved | 83 (32%) | 108 (33%) | 78 (33%) | 92 (36%) | 176 (45%) | 151 (47%) | 265 (42%) | 251 (41%) |
unchanged | 89 (35%) | 109 (33%) | 82 (35%) | 87 (34%) | 117 (30%) | 97 (30%) | 189 (30%) | 184 (30%) | |
worsen | 86 (33%) | 111 (34%) | 74 (32%) | 80 (31%) | 100 (25%) | 75 (23%) | 184 (29%) | 178 (29%) | |
Mobility | improved | 90 (19%) | 108 (19%) | 80 (21%) | 90 (22%) | 164 (43%) | 146 (48%) | 247 (36%) | 237 (36%) |
unchanged | 311 (64%) | 350 (63%) | 242 (63%) | 248 (61%) | 149 (39%) | 110 (36%) | 316 (46%) | 310 (46%) | |
worsen | 85 (17%) | 101 (18%) | 65 (17%) | 68 (17%) | 67 (18%) | 51 (17%) | 123 (18%) | 120 (18%) | |
Global Health | improved | 171 (26%) | 197 (26%) | 156 (29%) | 164 (29%) | 193 (37%) | 167 (39%) | 339 (33%) | 331 (33%) |
unchanged | 311 (47%) | 353 (46%) | 246 (45%) | 261 (45%) | 191 (36%) | 149 (35%) | 410 (40%) | 395 (39%) | |
worsen | 181 (27%) | 211 (28%) | 144 (26%) | 149 (26%) | 143 (27%) | 113 (26%) | 286 (28%) | 281 (28%) |